FDA Alerts

FDA
FDA
10/31/2018
The US Food and Drug Administration has approved adalimumab-adaz (Hyrimoz), a biosimilar to adalimumab (Humira), for the treatment of rheumatoid arthritis, juvenile...
10/31/2018
Rheumatologic disorders
Rheumatologic disorders
10/31/2018
menopause
menopause
10/26/2018
The FDA has approved a test to help determine a patient’s menopau
10/26/2018
Influenza
Influenza
10/24/2018
The US Food and Drug Administration has approved baloxavir marboxil (Xofluza)
10/24/2018
FDA
FDA
10/15/2018
More than 50% of adults in the US have reported consuming dietary supplements, according to the study authors. However, warnings from the FDA of potential undeclared, unapproved pharmaceutical ingredients...
10/15/2018
cardiovascular disease
cardiovascular disease
10/15/2018
New results from the COMPASS trial showed further cardiovascular benefits of rivaroxaban, when combined with aspirin. Find out the new indications here.
10/15/2018
HPV vaccination
HPV vaccination
10/09/2018
The FDA has expanded the age ranges of individuals who may receive the human papillomavirus 9-valent vaccine.
10/09/2018
HPV vaccination
HPV vaccination
10/09/2018
The FDA has expanded the age ranges of individuals who may receive the human papillomavirus 9-valent vaccine.
10/09/2018
Migraine
Migraine
10/01/2018
The new humanized monoclonal antibody acts by reducing the effect of CGRP, which is believed to have a physiologic role in migraine.
10/01/2018
Emerging Infections
Emerging Infections
09/19/2018
In an FDA statement, Scott Gotlieb, MD, discusses the pathogen added to the list of foodborne pathogens to routinely test for, why it was added, and the FDA’s ongoing efforts to screen domestic and imported...
09/19/2018